The cholinergic pathway involved in cognitive deficit and Alzheimer’s disease (AD) is the target of activity of the AChE enzyme that plays a role in breaking down or hydrolyzing acetylcholine, raising acetylcholine levels in the brain and resulting in improved cognitive functions in AD [33]. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.